• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Fact File: Industry scorecard on the ICD-10 delay

Article

The industry cost of ICD-10 implementation will total $8 billion, meanwhile many organizations have yet to move to the highly recommended testing phase

 

Industry scorecard on the ICD-10 delay

 

Who’s against the delay

  • Health insurers

  • American Health Information Management Assn.

  • American Medial Informatics Assn.

  • American Hospital Assn.

  • BlueCross BlueShield Assn.

NEXT: Who's for the delay >>>

 

 

 

 

Who’s for the delay

  • Some physicians and hospitals

  • U.S. House of Representatives

  • Medical Group Management Assn.

NEXT: Who's against ICD-10 overall >>>

 

 

 

 

Who’s against ICD-10 overall

 

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.